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INTRODUCTION  
 
 
 
 
 
 
 
INTRODUCTION 
 Emphysematous pyelonephritis (EPN) has been defined as a 
necrotizing infection of the renal parenchyma and its surrounding areas 
that results in the presence of gas in the renal parenchyma, collecting 
system, or perinephric tissue [1]. It is a relatively rare disease, life 
threatening, considered to be a urological emergency which traditionally 
required emergency nephrectomy and was associated with   a high 
mortality rate [42-80%]. Historically the prognosis in these patients has 
been poor.  
 The recent trend in management is along the lines of  conservative 
treatment  or a minimally invasive one , probably due to advent of newer 
highly effective antibiotics, better imaging and early diagnosis, superior 
supportive care and a set of prognostic factors available to base our 
treatment on [2].  
 The published series now available shows the evaluation of a small 
number of patients admitted in their institutions over a long period. In our 
institution we had a number of patients admitted with EPN within a short 
time interval. So I was motivated by my teachers to conduct this study in 
a large tertiary care hospital like our institute which has a very large case 
load. 
  
 
AIM  
 AIMS AND OBJECTIVES 
 
 The primary aim is to analyze and reappraise the available 
prognostic factors of emphysematous pyelonephritis, to study the 
outcomes of conservative treatment and the long-term renal function after 
conservative management in our institute. 
 The  secondary objectives are to study the epidemiology, etiology, 
clinical presentation, radiological findings, causative organism, mortality 
associated with emphysematous pyelonephritis 
 
  
 REVIEW OF 
LITERATURE 
 
                                    
REVIEW OF LITERATURE 
EPIDEMIOLOGY 
 Emphysematous pyelonephritis (EPN) is a life threatening 
necrotizing infection of the kidney characterized by accumulation of gas 
in the renal parenchyma and within the surrounding tissues. The first case 
was reported by Kelley and Mac Callum[3-4]. The condition is more 
common in females than males. Male to female ratio reported by Micheli 
and Perlberg was 2:1[5]. Left kidney (53%) was involved in most 
instances, right kidney in 35% and bilateral involvement in 7% according 
to one study. All of the documented cases of emphysematous 
pyelonephritis have occurred in adults (Hawes, 1983). Juvenile diabetic 
patients do not appear to be at risk.  
CAUSE AND PREDISPOSING FACTORS 
 It is commonly seen in patients with Diabetes Mellitus. Apart from 
DM the causes proposed are obstruction and infection[6]. The factors 
predisposing to EPN in patients with DM are poorly controlled Diabetes, 
calculus disease, obstruction, papillary necrosis and immunosuppression. 
The unrelieved urinary tract obstruction and hydronephrosis  may 
increase pelvicalyceal pressure and compromise renal circulation, and 
result in impaired transportation of gas and subsequent creation of a gas 
chamber (ie, EPN).  
ORGANISM 
 The most common organism in culture was Escherichia coli. 
Klebsiella , Proteus were less common[7-10]. Pseudomonas, clostridium, 
Candida, Aspergillus have also been reported. Mixed organisms have 
been reported in around 10% of cases.  
CLINICAL PRESENTATION 
 The usual clinical presentation is severe, acute pyelonephritis, 
although in some instances a chronic infection precedes the acute attack. 
They present with high grade fever with chills, rigors, flank pain. Almost 
all patients display the classic triad of fever, vomiting, and flank pain. 
Pneumaturia and foul smelling urine was reported in patients with 
emphysematous cystitis. Rarely patients can also present with septic 
shock and crepitant mass[11-15] 
PATHOPHYSIOLOGY OF GAS FORMATION 
 Various theories has been postulated for the mechanism of gas 
production. Most bacteria obtain their energy through the fermentation of 
glucose via the glycolytic pathway. Among these pathways, only mixed 
acid fermentation (most Enterobacteriaceae, eg, E coli, K pneumoniae, 
and Proteus) and butyric fermentation (Clostridium) can give rise to H2 
as an end product. Since the most common gas seen was H2 and CO2 
mixed acid fermentation of glucose by Enterobacteriaceae and rarely via 
butyric fermentation of glucose by anaerobes were the pathways by 
which emphysematous UTI developed. The trace amounts of NH3 and 
methane seen in some may have arisen from degradation of necrotic 
tissue and the fermentation of amino acids. 
 The mechanism of gas chamber (ie, large gas bubbles) formation 
has been hypothesized as a series of increased gas production, impaired 
transportation of gas by vascular compromise, creation of a gas chamber, 
equilibrium of gas chamber and tissue gas, and the expansion or collapse 
of a gas chamber.  
 Four  factors that may be involved in the pathogenesis of EPN, 
including gas-forming bacteria, high tissue glucose level, impaired tissue 
perfusion, and a defective immune response (such as DM). Yang and 
Shen indicated that gas forming infections depend on rapid tissue 
catabolism and impaired transport of end products at inflammatory site. 
Diabetic microangiopathy may also contribute to slow transport of 
catabolic products and may lead to accumulation of gas. 
 Although CO2 was released by bacteria, the final tissue 
equilibrium achieved by tissues and gas bubbles, determine the final CO2 
content[1][16-18] 
IMAGING OF EPN 
 The diagnosis is established radiographically. 
 Abdominal radiograph: Tissue gas that is distributed in the 
parenchyma may appear on abdominal radiographs as mottled gas 
shadows over the involved kidney. This finding is often mistaken for 
bowel gas. A crescentic collection of gas over the upper pole of the 
kidney is more distinctive. 
 Ultrasonogram: may be useful when gas was confined to renal 
parenchyma. At this stage dense echoes originating from within the 
identifiable renal cortex, most likely represents gas. If gas has entered the 
perinephric space and surrounding tissues the sonographic appearance 
was described as gassed out kidney, i.e because the ultrasound is totally 
reflected by the highly echogenic gas. The gas in the kidney has been 
described as dirty shadowing 
 Computerized Tomography: CT is the imaging procedure of 
choice in defining the extent of the emphysematous process and guiding 
management[19-21] 
RADIOLOGICAL CLASSIFICATION OF EPN 
 In 1970, Langston and Pfister described three main radiographic 
patterns[1]. 
Grade1: diffuse mottling of renal parenchyma 
Grade2: bubbly renal parenchyma surrounded by crescent shaped gas in 
the perinephric space 
Grade3: extension of gas through gerotas fascia 
 In 1984, Michaeli et al described three stages of Emphysematous 
pyelonephritis[5]. 
Stage1: gas within kidney 
Stage2: presence of gas in kidney and perinephric tissue 
Stage3: extension of gas through gerotas fascia or bilateral 
emphysematous pyelonephritis 
 In 1996, Wan et al described two distinct types of emphysematous 
pyelonephritis [10] 
Type1: characterized by extensive parenchymal destruction with absence 
of fluid collections and presence of mottled gas (Dry type)- Mortality: 
69%. 
Type2: characterized by renal or perirenal collections with bubbly or 
loculated gas or gas in collecting system( Wet type)- Mortality: 18%. 
 1n 2000, Huang et al modified the staging proposed by Michaeli et 
al [1] 
Class1:  gas confined to renal pelvis or emphysematous pyelitis 
Class2: gas in renal parenchyma 
Class3A: gas in perinephric tissue or abscess 
Class3B: gas extension beyond gerotas fascia 
Class4: bilateral involvement or EPN in solitary kidney 
 The classification of Wan et al and Huang et al were based on CT 
scan findings whereas the classification of Langston and Michaeli were 
based on plain X rays. 
PROGNOSTIC FACTORS  
 Risk factors in EPN which are described in literature are acute 
renal insufficiency, thrombocytopenia, proteinuria, shock during 
presentation, altered sensorium, sepsis, hyponatremia, , uncontrolled DM. 
Patients with more than two risk factors had poor prognosis and 
irrespective of class of EPN required surgical treatment. 
 It has been supposed that high tissue glucose levels may be a risk 
for EPN to develop and cause a fulminant course in patients with DM, 
because it can provide gas forming microbes with a microenvironment 
more favorable for growth and rapid catabolism. 
 Thrombocytopenia was most likely due to disseminated 
intravascular coagulation in these severe cases. Actually, most of them 
also had prolongation of prothrombin time and activated partial 
thromboplastin time and increased serum fibrin degradation products or 
fibrin degradation product dimmers. 
 Disturbance of consciousness implicated dysfunction of the central 
nervous system, which might be due to poor perfusion or metabolic 
factors. Shock was a sign of collapse of the cardiovascular system. All of 
the aforementioned signs may represent a dysfunction of the hematologic 
system, kidney(s), central nervous system, and cardiovascular system, 
respectively. 
 The cause of severe proteinuria was multifactorial. Fever, 
underlying glomerulonephritis, and diabetic nephropathy all can 
contribute to severe proteinuria.[1] [22-24] 
 Any analysis of the outcome of patients with DM who are septic, 
independent of a diagnosis of EPN, may reveal the same prognostic 
determinants, ie, shock, severe proteinuria, thrombocytopenia, acute renal 
function impairment, and disturbance of consciousness. They are not 
unique to EPN and may be applied to other patients with DM and sepsis. 
 
MANAGEMENT 
 Emphysematous pyelonephritis was considered as a surgical 
emergency in the past. Most patients are septic, and fluid resuscitation 
and broad-spectrum antimicrobial therapy are essential. 
 Earlier investigators recommended that early aggressive surgical 
intervention, along with medical treatment, could decrease the mortality 
rate in patients with EPN. Klein et al. [25] reviewed 66 reported cases of 
EPN and found an overall mortality rate of 38%, i.e. 71% in medically 
treated patients and 29% in those surgically treated. Others [26,27,28] 
concluded that vigorous resuscitation and appropriate medical treatment 
should be attempted, but immediate nephrectomy should not be delayed, 
for the successful management of EPN.  
 In recent years there has been a gradual shift in the management 
strategy, where more minimally invasive approaches have become 
important. Hudson et al [27] first described fluoroscopically guided PCD 
for treating EPN, with successful clinical results. This report was 
followed by many series showing the good outcomes with US- or CT-
guided PCD. 
  
 
  
  
MATERIALS 
AND 
METHODS 
  
MATERIAL AND METHODS 
STUDY POPULATION:   Patients admitted to our hospital in various 
departments with diagnosis of EPN made on CT findings 
NATURE OF STUDY:  Prospective and Retrospective study 
NO. OF CASES:  52 
STUDY PERIOD:  September 2009 to January 2012 
INCLUSION CRITERIA:  
All patients admitted with diagnosis of EPN to our hospital within 
this study period 
EXCLUSION CRITERIA:  
Fistulous communication between urinary tract and gastrointestinal 
system 
History of recent genitourinary trauma 
 
 
 
METHODOLOGY 
The diagnosis of EPN was confirmed by CT KUB scan 
The clinical presentation was documented 
Routine blood and urine investigations was done 
Prognostic factors were investigated 
1. Sepsis 
2. Shock 
3. Altered sensorium 
4. Need for dialysis 
5. Thrombocytopenia 
Other factor investigated was 
1. Glycemic control 
 
 
Patients were classified based on CT scan findings according to Huang et 
al 
The patients who presented with sepsis and shock were resuscitated and 
supportive care was given and started on treatment either conservative, 
minimally invasive or extensive management 
Other co morbid conditions were treated simultaneously 
Conservative management includes 
Antibiotic therapy and supportive measures 
Patients were started on broad spectrum antibiotics, Piperacillin 
Tazobactum, Cefoperazone Sulbactum and then changed to culture 
specific antibiotics 
Minimally invasive management includes 
DJ stenting 
Percutaneous nephrostomy 
Percutaneous drainage 
 
Extensive management includes 
Open drainage 
Nephrectomy 
The indications for minimally invasive management were 
1. Obstructed system[ hydroureteronephrosis] 
2. Sepsis 
3. Significant renal and perirenal collection[ class 2 and 3] 
 The indications for extensive management were 
1. Persisting sepsis 
2. Persisting collection 
The patients were considered cured based on the clinical features and 
repeat CT scans done 
DTPA renogram was done at least 4 weeks after complete resolution and 
discharge from the hospital 
 
RISK FACTORS DESCRIPTION 
Thrombocytopenia: was defined as Platelet count less than 1.0 lakhs 
Shock: was defined as systolic blood pressure less than 90mm Hg 
Altered sensorium: was defined as a state of confusion or delirium, stupor 
or coma. 
Acute renal function impaired: was defined as elevation of serum 
creatinine of more than 0.5 mg in normal patients and more than 1 mg in 
CKD patients. Need for dialysis was considered a risk factor. 
Sepsis: was defined as  
(1) Temperature [>38
0
C /<36
0
C] 
(2) Heart rate>90 / minute 
(3) Respiratory rate >20 per minute 
(4) WBC count >12,000/mm3 or<4,000/mm3 
 
 
 
STATISTICAL ANALYSIS 
  Statistical analysis was done using SPSS version 17.0 software. To 
compare mean values t- test was used and to compare proportions Chi-
square test was applied.  
 
 
 
 
 
 
 
 
 
  
OBSERVATION 
AND RESULTS 
 
 
OBSERVATIONS AND RESULTS 
 The study comprised of 52 patients who were admitted and treated 
for EPN and followed-up from September 2009 to January 2012 and who 
satisfied the inclusion and exclusion criteria. 
BASELINE CHARACHTERISTICS 
AGE, GENDER, ETIOLOGY 
  The patients’ age ranged from 34 to 68 years with the mean age 
being 51 years. There were 38 female patients and 14 male patients. 
TABLE 1: GENDER DISTRIBUTION 
 SEX NO OF PATIENTS 
1 Female 38 
2 Male 14 
 TOTAL 52 
  
 50 (96.15%) patients had Diabetes Mellitus. 14 of the 50 diabetic 
patients (28%) had obstruction. The other 2 patients without diabetes had 
obstructed system due to calculus disease, one in the pelvis, other in the 
ureter. All the patients with DM had HbA1C level greater than 8, i.e 
poorly controlled DM. Mean HbA1C level was 11.05. 
CLINICAL PRESENTATION 
 Most of the patients presented with fever, loin pain and dysuria. 
These were nonspecific and was seen as in any other urinary tract 
infection. Risk factors seen were sepsis in 37 (71.15%) patients, shock in 
14 (26.92%) patients, thrombocytopenia in 30 (57.69%) patients, altered 
sensorium in 5 (9.16%) patients. Renal function was impaired in 38 
(73.07%) patients but only 5 (9.16%) needed dialysis and none became 
dialysis dependant after treatment. 
TABLE 2: CLINICAL FEATURES DISTRIBUTION 
S.NO 
CLINICAL FEATURES NUMBER (PERCENTAGE) 
1 FEVER 46 (88.46%) 
2 LOIN PAIN 36(69.23%) 
3 DYSURIA 40(76.92%) 
RISK FACTORS 
1 SEPSIS 37 (71.15%) 
2 SHOCK 14 (26.92%) 
3 ALTERED SENSORIUM 5 (9.16%) 
4 THROMBOCYTOPENIA 30 (57.69%) 
5 NEED FOR DIALYSIS 5 (9.16%) 
6 POORLY CONTROLLED DM 50(96%) 
 
MICROBIOLOGY 
 E.Coli was the most common organism cultured.The other 
organism cultured were Klebsiella, Proteus and Pseudomonas. Mixed 
culture was seen in 2 (3.85%) patients and no growth was seen in 2 
(3.85%) patients with obstructive stone disease. 
 
TABLE 3: DISTRIBUTION OF ORGANISM CULTURED 
 
S.NO ORGANISM NUMBER(PERCENTAGE) 
1 E.COLI 39(75%) 
2  KLEBSIELLA 5 (9.16%) 
3 PROTEUS 3 (5.77%) 
4 PSEUDOMONAS 1(1.92%) 
5 MIXED CULTURE 2 (3.85%) 
6 NO GROWTH 2 (3.85%)/ STONE 
 
 
 
 
RADIOLOGICAL CLASSIFICATION 
 Class II was the most common class which was seen in 18 
(34.61%) patients. 9 (17.31%) of patients had Class I, 10 (19.23%) had 
Class III A, 8(15.38%) had Class III B and 6 (11.54%) had Class IV.  
TABLE 4: DISTRIBUTION OF CLASS 
 
S.NO CLASS NUMBER (PERCENTAGE) 
1 CLASS I 9 (17.31%) 
2 CLASS II 18 (34.61%) 
3 CLASS III A 11 (21.15%) 
4 CLASS III B 8(15.38%) 
5 CLASS IV 6 (11.54%) 
 TOTAL 52 
  
 
FIGURE 1: DISTRIBUTION OF CLASS OF EPN 
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MANAGEMENT 
 
 18 (34.61%) patients were treated conservatively with antibiotic 
alone. Even minimally invasive intervention was not needed in these 
patients. All the patients had complete resolution of signs and symptoms. 
 20 (38.46%) patients were treated with minimally invasive 
treatment which included    1) percutaneous drainage, 2)stenting, 
3)percutaneous nephrostomy along with antibiotics. Stenting was done in 
14 (26.92%) patients, as a primary procedure in 7 patients and as an 
adjunctive procedure to percutaneous drainage and open drainage in 7 
patients.  In one patient stenting was done for urine leak through the drain 
tube following percutaneous drainage. The drainage stopped and 
symptoms resolved and the stent was removed after 4 weeks. 
 Percutaneous nephrostomy was done in 2 patients with stone 
disease and obstructed system following which the stones underwent 
appropriate treatment 1) pelvic calculus- ESWL and 2) ureteric calculus- 
URS and Lithotripsy.  
 12 (19.23%) patients had open drainage (OD) either because of 
loculated collection seen on CT or due to persistent collection and sepsis 
after percutaneous drainage. O ne patient proceeded to nephrectomy and 
2 patients succumbed to death. 
 3 (5.77%) patients had to undergo nephrectomy due to persistent 
sepsis    (for 2 of them- PCD done previously and 1 of them- OD done 
before nephrectomy). 2 patients succumbed to death despite drainage and 
supportive measures and the mortality rate was 2.85%.  
 
TABLE 5: TREATMENT DISTRIBUTION 
 
S. NO Rx NUMBER (PERCENTAGE) 
1 ANTIBIOTICS 18 (34.61%) 
2 MINIMALLY INVASIVE 20 (38.46%) 
2 A PCD 7 (13.46%) 
2 B PCD + STENTING 4 (7.69%) 
2 C STENTING  7 (13.46%) 
2 D PCN 2 (3.85%) 
3 OPEN DRAINAGE 11 (21.15%) 
(3 WITH STENTING 
2 MORTALITY) 
4 NEPHRECTOMY 
 
3 (5.77%) 
(2 AFTER PCD 
1 AFTER OPEN DRAINAGE) 
 
 
 FIGURE 2: TREATMENT DISTRIBUTION 
 
 
 
CLASS AND TREATMENT 
 
 For class I, class II and class IV the predominant mode of 
management was less invasive management. For class III B the 
predominant mode of treatment was invasive drainage and nephrectomy. 
For class III A, equal percentage of people were managed with open 
drainage and minimally invasive treatment. 
 
 
 
 
 
 
 
ANTIBIOTICS 
18, 35% 
MINIMALLY 
INVASIVE, 20, 38% 
OPEN DRAINAGE 
11, 21% 
NEPHRECTOMY 
3, 6% 
ANTIBIOTICS 
MINIMALLY INVASIVE 
OPEN DRAINAGE 
NEPHRECTOMY 
TABLE 6: CLASS AND TREATMENT 
CLASS TREATMENT  
ANTIBIOTICS MINIMALLY 
INVASIVE 
OPEN 
DRAINAGE 
NEPHRECTOMY MORTALITY 
I (9) 7 2 - - - 
II (18) 7 11 - - - 
III A 
(11) 
 
- 5 4 2 - 
III B 
(8) 
- 0 5 1 2 
AFTER OPEN 
DRAINAGE 
IV 
(6) 
4 2 - - - 
   
FIGURE 3: CLASS VS TREATMENT 
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TABLE 7: RISK FACTORS AND TREATMENT 
 
NO OF  
RISK  
FACT
ORS 
NO OF 
 
PATIE
NTS 
TREATMENT 
 
 
MORTA
LITY 
(2) ANTIBIO
TICS 
(18) 
MINIMA
LLY 
INVASIV
E 
(20) 
OPEN 
DRAIN
AGE 
(8) 
NEPHRECT
OMY 
(3) 
0 12 11 1 - - - 
1 5 2 2 1 - - 
2 23 4 13 6 - - 
3 10 1 4 2 3 - 
5 2 - - - - 2 
  
 There were 12 patients with no risk factors of whom 11 were 
managed with antibiotics. We had 5 patients with 1 risk factor. 1of them 
had to undergo open drainage because of the extent of infection despite 
the presence of just 1 risk factor. There were 23 patients with 2 risk 
factors in whom the predominant mode of treatment was less invasive 
management (Antibiotics- 4 and Minimally Invasive treatment- 13). Both 
patients with 5 risk factors died despite treatment.  
FIGURE 4: RISK FACTORS VS TREATMENT 
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TABLE 8: PREDOMINANT NUMBER OF RISK FACTOR 
ASSOCIATED WITH TREATMENT 
 
 
 
TREATMENT 
RISK FACTORS 
PREDOMINANT 
NO  OF  RISK 
FACTOR (RF) 
NUMBER/ 
PERCENTAGE 
ANTIBIOTICS (18) 0RF 11 (61.11%) 
MINIMALLY  
INVASIVE Rx (20) 
2RF 13 (65%) 
OPEN DRAINAGE(8) 2RF 6 (75%) 
NEPHRECTOMY (3) 3RF 2 (66.67%) 
MORTALITY (2) 5RF 2 (100.0%) 
 
 The patients managed with antibiotics were predominantly 
associated with no risk factors (61.11%). Patients managed with 
minimally invasive treatment and with open drainage were predominantly 
associated with 2 risk factors (65 and 75% respectively). Patients 
managed with nephrectomy were predominantly associated with 3 risk 
factors. This depicts that presence of 2 risk factors is significantly 
associated with some form of surgical intervention- minimally invasive or 
extensive treatment. 
 
 
 
 OUTCOMES 
 
 
 Of the 52 patients 50 patients survived. 3 pateients had to lose their 
kidney for survival to control sepsis. Only 2 patients died and the 
mortality rate (3.85%) was very low compared to other studies and the 
survival rate high (96.15%). 
 
 
TABLE 9: OUTCOME IN PATIENTS 
 
OUTCOMES NUMBER (PERCENTAGE) 
SURVIVED 50 (96.15%) 
LOSS OF 1 RENAL UNIT 3 (5.77%) 
MORTALITY 2 (3.85%) 
 
 
 
 
 
 
 
 
 
 
TABLE 10: TREATMENT AND SUCCESS 
S.N
O 
MANAGEME
NT 
NO (%) OF PATIENTS  
  SUCCESSFUL FAILURE  
1. ANTIBIOTICS 
ALONE 
18/18 
(100%) 
  
2. MI ALONE 20/26 
(76.92%) 
 4/6 PROCEEDED TO OD 
(1 DIED) 
 2/6 PROCEEDED TO 
NEPHRECTOMY 
 
 
3. OPEN 
DRAINAGE 
9/12 
(71.43%) 
 1/12 PROCEEDED TO 
NEPHRECTOMY 
 2/12 MORTALITY  
 
   
 
 All the treatment modalities had high success rates considering loss 
of renal unit and mortality as failure. Of the 26 patients started with 
minimally invasive line of treatment 4 PCD proceeded to open drainage 
one of whom died and 2 PCD progressed to nephrectomy. Of the 12 
patients who underwent open drainage 8 patients had OD as their primary 
treatment and 4 patients underwent OD after PCD. Of the 8 patients ( OD 
as 1
0 
treatment) 1 progressed to nephrectomy and 1 died. 
 
 FOLLOW-UP AND RESIDUAL RENAL FUNCTION 
 Patients’ follow-up ranged from 2 to 28 months and the mean 
follow-up duration was 16.27 months. 8 patients had repeated symptoms 
and were diagnosed to have minimal parenchymal disease class II and 
were managed conservatively with antibiotics and all of them were cured.  
 Nuclear renogram with DTPA was done in all the patients at least 1 
month after cure and discharge. The residual renal function in 47 patients 
and 53 renal units ranged from 14 to 48% on the affected side and the 
mean residual renal function was 31.79%.  
 The residual renal function was compared with class of EPN and 
type of treatment. The residual function was poor in class 3 patients with 
mean residual function of 18.15% compared to  36.70% mean residual 
function in other classes, which was very significant with p-value <0.01.  
 The mean residual renal function in the patients undergoing open 
drainage was 16.38% when compared to others treated less invasively 
which was 34.76%, which is again very significant with a p-value of 
<0.01. Whether this is due to the severe class of patients treated with 
open drainage, needs to be studied further. 
 TABLE 11: INDEPENDENT SAMPLES T-TEST TO COMPARE 
THE MEAN RENAL FUNCTION VALUES BETWEEN CLASS III 
AND OTHER CLASS 
 
 
TYPE OF 
CLASS 
N MEAN 
STD. 
DEV 
T-
VALUE 
P-
VALUE 
RENAL 
FUNCTION 
 CLASS 
III 
13 18.15 4.79 
7.8655 <0.0001 
OTHERS 34 36.70 7.92 
 
 
TABLE 12: INDEPENDENT SAMPLES T-TEST TO COMPARE 
THE MEAN RENAL FUNCTION VALUES BETWEEN OPEN 
DRAINAGE AND OTHER TREATMENT TYPES 
 
TYPE OF 
RX 
N MEAN 
STD. 
DEV 
T-
VALUE 
P-
VALUE 
RENAL 
FUNCTION 
OTHERS  39 34.76 9.12 
0.0001 < 0.001 
OD 8 16.38 1.69 
 
 
 
  
  
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
DISCUSSION 
 
 EPN is usually described as a relatively rare disease of the renal 
parenchyma considering the number of patients with diabetes and acute 
pyelonephritis. Initially multiple case reports of EPN were published 
describing the varied presentation and successful treatment. In 2000, 
Huang et al[1] published his landmark paper describing the success of 
conservative management and established the risk factors and their use as 
a guide in deciding treatment and predicting prognosis. It forms the basis 
of many studies. In India study published by Karthikeyan et al[2] is a 
very important considering the number of patients. In 1996 Wan et al [24] 
published his study and classified EPN into dry and wet type. In 1984 
Micheli et al [5] classified EPN on which Huang et al based his 
classification. 
 
 
 
BASELINE CHARACTERISTICS- ANALYSIS 
 Huang et al studied 48 patients in 11 years which is the largest 
reported study so far. Karthikeyan et al studied 42 patients in 6 years. In 
our hospital we encountered a large number of patients and studied 52 
patients in a short time of 3 years. The incidence of EPN seems to be on 
the higher side. 
 All the patients admitted in our institute were of the lower strata of 
the society and hence we were not able to study the influence of 
socioeconomic status on this disease. 
 The mean age group of presentation described by Huang and 
Karthikeyan in their study was 53.2 and 60 years respectively. In our 
study the mean age group of presentation of patients was 50.15. The 
youngest was 34 and the oldest was 68 years old. 
 EPN was always common in female patients. The female to male 
ratio in Huang et al is 41:7 and in Wan et al is 6:1. In our study the ratio 
was 5.4:2. The preponderance in females was supposed to be the 
increased susceptibility of UTI in females. The incidence of DM in 
Huang, Karthikeyan, Ali Nawaz [29] series was 96%, 93% and 97%. In 
our study 50 out of 52 (96.15%) had DM. 
 
ANALYSIS OF THE OUTCOMES AND RISK FACTORS 
 The mortality rate was very low, i.e 2/52 (3.85%) and none of the 
patients became dialysis dependant and the mean residual renal function 
was good. So the patients were divided into 2 groups. Group1-The 
patients who underwent open surgery (open drainage and nephrectomy) 
and those who died were considered to have poor outcomes and Group2-
those who underwent antibiotic treatment and minimally invasive 
management were considered to have good outcome. So, all the variables 
and prognostic factors were analyzed with regard to these outcomes. 
 
TABLE 13: CATEGORIZATION INTO OUTCOME GROUPS 
 
GROUP CATEGORY 
CRITERIA 
OUTCOMES 
CLASS 
NUMBER 
1 ANTIBIOTIC Rx 
MINIMALLY 
INVASIVE Rx 
GOOD OUTCOME 38 
2 OPEN SURGERY 
MORTALITY 
POOR OUTCOME 14 
 
 
 
 
AGE, GENDER AND OUTCOME 
 
 Age and gender of the patients were not significantly associated 
with outcomes and hence does not have any prognostic value 
 
TABLE 14: INDEPENDENT SAMPLES T-TEST TO COMPARE 
THE MEAN AGE BETWEEN OUTCOMES 
 OUTCOME NUMBER MEAN STD. DEV T-VALUE P-VALUE 
AGE 
GOOD 38 52.63 9.442 
0.692 0.493 
POOR 14 51.14 5.655 
 . 
TABLE 15: INDEPENDENT SAMPLES T-TEST TO COMPARE 
THE GENDER BETWEEN OUTCOMES 
GENDER 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N % N % N % 
MALE 12 75.0 4 25.0 16 100.0 
0.043 0.835 FEMALE 26 72.2 10 27.8 36 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
  
 
 
CLASS AND OUTCOME 
 Here in this table we can see the trend, that different classes are 
significantly associated with outcomes. The classes I and II and IV have 
all their patients in the good outcome group. The class III B has all their 
patients in poor outcome group. The association between class difference 
and outcome is statistically significant with a p- value of 0.01 
TABLE 16: ANALYSIS OF CLASS WITH OUTCOME 
CLASS 
Outcome 
Total 
2-
Value 
P-Value Good Poor 
N %   N % 
I 9 100.0 0 0.0 9 100.0 
38.138 <0.001 
II 18 100.0 0 0.0 18 100.0 
IIIA 5 45.5 6 54.5 11 100.0 
IIIB 0 0.0 8 100.0 8 100.0 
IV 6 100.0 0 0.0 6 100.0 
Total 38 73.1 14 26.9 52 100.0 
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SEPSIS AND OUTCOME 
 
 The number of patients who presented with sepsis were 37 and was 
found to be distributed in both groups and was not statistically associated 
with any outcome as an individual prognostic factor 
TABLE 17: SEPSIS AND OUTCOME 
SEPSIS 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N %   N % 
NO 13 86.7 2 13.3 15 100.0 
1.127 0.288 YES 25 67.6 12 32.4 37 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
     
 . 
 
 
 
NEED FOR DIALYSIS AND OUTCOME 
 Need for dialysis shows a trend towards poor outcome but was not 
found to be statistically significant  as a individual prognostic factor. 
TABLE 18: DIALYSIS NEED AND OUTCOME 
NEED 
FOR 
DIALYSIS 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N % N % N % 
NO 36 76.6 11 23.4 47 100.0 
1.497 0.221 YES 2 40.0 3 60.0 5 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
 
 
FIGURE 6: ANALYSIS OF SEPSIS AND DIALYSIS WITH 
OUTCOMES 
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SHOCK AND OUTCOME 
 14 patients presented with shock. Shock was associated with poor 
outcomes with a significant p-value of 0.023 and a very strong individual 
prognostic factor. 
 
TABLE 19: SHOCK AND OUTCOMES 
 
SHOCK 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N %   N % 
NO 31 81.6 7 18.4 38 100.0 
5.186 0.023 YES 7 50.0 7 50.0 14 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
  
 
ALTERED SENSORIUM AND OUTCOME 
 Altered sensorium was seen in 5 patients, all of them in poor 
outcome group and was significantly associated with poor outcome with a 
p-value of 0.01. 
 
TABLE 20: ALTERED SENSORIUM AND OUTCOMES 
ALT 
SENSORI
UM 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N %   N % 
NO 38 80.9 9 19.1 47 100.0 
11.187 0.001 YES 0 0.0 5 100.0 5 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
  
THROMBOCYTOPENIA AND OUTCOME 
 The thrombocytopenia was seen in 30 patients and is seen 
statistically associated with outcome with a p-value of 0.013 and 
considered an individual prognostic factor. 
TABLE 21: THROMBOCYTOPENIA AND OUTCOMES 
THROMBO
CYTOPENI
A 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALU
E 
GOOD POOR 
N % N % N % 
NO 20 90.9 2 9.1 22 100.0 
6.613 0.013 YES 18 60.0 12 40.0 30 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
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NUMBER OF RISK FACTORS AND OUTCOME 
  
 Huang et al study states that presence of 2 or more risk factors 
portend a poor prognosis which in their case was mortality. Karthikeyan 
et al study shows that 2 or more risk factor predicts some form of 
intervention to which we concur.  
TABLE 22: NUMBER OF RISK FACTORS AND OUTCOME 
NUMBER 
OF RISK 
FACTORS 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N %   N % 
0 15 100.0 0 0.0 15 100.0 
12.686 0.013 
1 4 100.0 0 0.0 4 100.0 
2 16 73.9 6 26.1 22 100.0 
3 4 66.67 2 33.33 6 100.0 
4 0 0.0 4 100.0 3 100.0 
5 0 0.0 2 100.0 2 100.0 
TOTAL 38 73.1 14 26.9 52 100.0 
 This table definitely depicts that the number of risk are very 
significantly associated with outcomes with a p-value of 0.013. The trend 
shows that patients with no or up to 2 risk factors are associated with 
good outcome. The presence of 3 and more risk factors are associated 
with poor outcome  
FIGURE 8: 
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DKA AND OUTCOMES 
 Suganadh shetty [30] in his series reported a high incidence of 
mortality in patients with DKA. Proper supportive care and close 
intensive monitoring is an absolute necessity of improved survival in 
these patients.  
 
TABLE 23: DKA AND OUTCOME 
DKA 
Outcome Total 
2-Value P-Value Good Poor 5.00 6.00 
N % N % N % 
No 31 81.6 7 18.4 38 100.0 
5.186 0.023 Yes 7 50.0 7 50.0 14 100.0 
Total 38 73.1 14 26.9 52 100.0 
  
 DKA was seen in 14 patients and was found to be statistically 
associated with poor outcome with a significant p-value of 0.023. 
 
 
FIGURE 9: 
 
 
 
HBAIC AND OUTCOMES 
 It is proposed that high tissue glucose levels may be a risk for EPN 
to develop and cause a fulminant course in patients with DM, because it 
can provide gas forming microbes with a microenvironment more favor 
able for growth and rapid catabolism 
 In our study HbA1C was studied as a prognostic factor. They were 
divided into 3 groups 1) < 11, 2) 11-13, 3) > 13.  The mean HbA1C level 
in our series was 11.04. The patients with higher HbA1C level, i.e poor 
diabetic control was associated with higher class of EPN. 
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TABLE 24: HBA1C AND OUTCOMES 
HBA1C 
GROUP 
OUTCOME 
TOTAL 
2-
VALUE 
P-
VALUE 
GOOD POOR 
N %   N % 
< 11.0 26 100.0 0 0.0 26 100.0 
21.655 <0.001 
11.0 - 
13.0 
5 50.0 5 50.0 10 100.0 
>13.0 5 35.7 9 64.3 14 100.0 
TOTAL 36 72.0 14 28.0 50 100.0 
  
 In our study the poor glycemic control was associated with 
outcomes with a significant p-value. HbA1C levels <11 were associated 
with good outcome and > 13 were significantly associated with poor 
outcome. In Huang et al study poor glycemic control was not associated 
with poor prognosis and hence was not considered a prognostic factor. 
We propose based on our study that HbA1C level can be used as a 
prognostic factor.  
FIGURE 10: 
 
 
SUMMARY OF ANALYSIS  
 Class of EPN and number of risk factors were significantly 
associated with outcome. Shock, thrombocytopenia and altered sensorium 
were significant individual risk factors. DKA and poor glycemic control 
are associated with poor outcomes with statistical significance. 
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TABLE 25: BASELINE CHARACTERISTICS AND RISK 
FACTORS IN GOOD AND POOR OUTCOME GROUPS- 
SUMMARY 
VARIABLES GOOD 
OUTCOME 
(38) 
POOR 
OUTCOME 
(14) 
P VALUE 
 
BASELINE CHARACTERISTICS 
       MEAN AGE 52.63 51.14 0.493 
       SEX     
 MALE  12  4  0.835 
FEMALE  26  10  
       HBA1C > 8     
< 11.0 26 0 < 0.001 
11.0- 13.0 5 5 
>13 5 9 
       DKA 7 7 0.023 
 
RISK FACTORS 
       SEPSIS 25  12  0.288 
       SHOCK  7 7 0.023 
       THROMBOCYTOPENIA   18 12 0.013 
       NEED FOR DIALYSIS 2  3 0.221 
       ALTERED SENSORIUM 0 5 0.001 
 
 
 
NEPHRECTOMY AND OUTCOME 
 The emergency nephrectomy rates was 42% in Huang et al study 
and 3% in Karthikeyan et al study and 25% in Rakesh kapoor et al study. 
In our study none were managed with emergency nephrectomy. Both the 
patients who underwent nephrectomies were managed initially with 
minimally invasive treatment. According to study by Chang et al and 
Rakesh Kapoor emergency nephrectomy was associated with high 
mortality rates of 42% in both. Our study also proves that conservative 
and appropriate minimally invasive treatment has a good outcome with 
good preservation of renal function. 
 
MORTALITY 
 The mortality rates of Huang et al, Karthikeyan and Chuang et al 
studies were 18.8%, 17% and 42% respectively. In our study the 
mortality rate was a mere 3.85%. In Rakesh kapoor et al [13] study the 
presence of altered mental status, thrombocytopenia, renal failure was 
associated with higher mortality rates. In our study the mortality rate was 
only 3.85% but both of them were associated with 5 risk factors. 
 
 SYNOPSIS OF RESULTS 
 The age and gender distribution in our study is similar to those in 
other studies and they do not influence the outcome of the patients. 
 Diabetes mellitus is the most common cause of EPN and all the 
patients in our study had poor glycemic control. 
 E.coli was the most common organism to be cultured. 
 Class II EPN was the most predominant type of EPN. The 
classification into different groups were significantly associated 
with the outcomes, with a p-value <0.01 and class III B had poor 
outcome. 
 Shock, altered sensorium and thrombocytopenia were the risk 
factors which were significantly associated with poor outcomes 
with a p-value <0.05 
 Up to 2 risk factors was associated good outcome and 3 and more 
risk factors were associated with poor outcomes. The presence of 2 
risk factors predicts some of intervention 
 In our study we have found the statistically significant association 
between the presence of DKA and increasing HBA1C levels to 
poor outcomes, hence we recommend its use as one another risk 
factor. 
 No patient was managed with emergency nephrectomy. 
 Mortality was seen in only 2 patients but both of them had all the 5 
risk factors, probably the reason being the onset of SIRS and 
irreversible septic shock. We were not able to derive any statistical 
conclusion because of the very low number. 
 
 
 
 
  
CONCLUSION 
 
 
 
 
 
 
 
 CONCLUSION 
 
 Emphysematous pyelonephritis can be successfully managed with 
conservative management in most patients irrespective of class.Minimally 
invasive treatment is the first line of management even in extensive 
parenchymal disease and is a successful one too. Conservative and early 
intervention can prevent mortality and nephrectomies. 
 Reappraisal of the existing prognostic factors using a multivariate 
analysis shows that 3 or more risk factors predict a poor outcome and 2 or 
more factors predict intervention. The prognostic factors shock, 
thrombocytopenia, altered sensorium are more significantly related. 
 The residual renal function was significantly preserved with 
conservative and minimally invasive line of management. 
 DKA and poor glycemic control (HbA1C level) significantly 
predict poor outcomes and hence should be added as a prognostic tool.  
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APPENDIX 
 
 
 
 
 
  
INFORMED CONSENT FORM 
        
Title of the study: ”Emphysematous pyelonephritis- reappraisal of 
prognostic factors, analysis of outcomes and long-term renal function”. 
Name of the Participant:  
Name of the Institution: Dept. Of Urology 
  Madras Medical College 
  Rajiv Gandhi Govt General Hospital. 
Name and address of the sponsor / agency (ies) (if any): None 
Documentation of the informed consent 
I _____________________________ have read the information in this 
form (or it has been read to me). I was free to ask any questions and they 
have been answered. I am over 18 years of age and, exercising my free 
power of choice, hereby give my consent to be included as a participant 
in ”Emphysematous Pyelonephritis- Reappraisal Of Prognostic 
Factors, Analysis Of Outcomes And Long-Term Renal Function”. 
I have read and understood this consent form and the information 
provided to me. 
I have had the consent document explained to me. 
I have been explained about the nature of the study. 
I have been explained about my rights and responsibilities by the 
investigator. 
I have been informed the investigator of all the treatments I am taking or 
have taken in the past________ months including any native (alternative) 
treatment. 
I have been advised about the risks associated with my  participation in 
this study. 
I agree to cooperate with the investigator.  
I am aware of the fact that I can opt out of the study at any time without 
having to give any reason and this will not affect my future treatment in 
this hospital.  
 I am also aware that the investigator may terminate my participation in 
the study at any time, for any reason, without my consent.  
 I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I understand that they are 
publicly presented. 
I have understand that my identity will be kept confidential if my data are 
publicly presented. 
I have had my questions answered to my satisfaction. 
I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
given in this document has been clearly explained to me and understood 
by me, I will be given a copy of this consent document. 
 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
Name _________________________ Signature_________________  
Date________________ 
 
Name and Signature of impartial witness (required for illiterate 
patients): 
Name _________________________ Signature_________________  
Date________________ 
 
Address and contact number of the impartial witness: 
 
Name and Signature of the investigator or his representative 
obtaining consent: 
Name _________________________ Signature_________________  
Date________________ 
PROFORMA 
NAME:   
AGE :  
ADDRESS:  
CONTACT  NUMBER: 
IP  NO./ OP NO.:                             
STUDY  TYPE         :   Prospective and Retrospective  study 
INCLUSION CRITERIA:    
 All patients admitted with diagnosis of EPN to our hospital within 
this study period 
EXCLUSION CRITERIA:  
History of recent urinary tract catheterization and instrumentation 
Fistulous communication between urinary tract and gastrointestinal 
system 
History of recent genitourinary trauma 
METHOD: 
 Admission 
 The diagnosis confirmed by CT KUB scan 
 The clinical presentation was documented 
 Routine blood and urine investigations done 
 Prognostic factors were investigated  
 Treatment given appropriately 
 DTPA scan done later for residual renal function 
 Analysis of existing prognostic factors and outcomes 
and residual renal function 
 
 
 Statistical   analysis   done   using the SPSS   Software.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
